Kamada Limited (KMDA) CEO Amir London on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/11/21
Kamada Reports Second Quarter and First Half 2021 Financial Results, Recent Achievements and Corporate Development ActivitiesGlobeNewsWire • 08/11/21
Analysts Estimate Kamada (KMDA) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 08/04/21
Kedrion and Kamada Announce FDA Approval of KEDRAB® Label Update, Confirming Safety and Effectiveness in ChildrenPRNewsWire • 06/02/21
Kamada's (KMDA) CEO Amir London on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/12/21
Kamada Reports First Quarter 2021 Financial Results, Recent Achievements and Corporate Development ActivitiesGlobeNewsWire • 05/12/21
Kamada Reports Top-line Data Of Plasma-Derived IgG Treatment From Early-Stage COVID-19 TrialBenzinga • 03/31/21
Kamada Announces Top-line Results from its Phase 1/2 Clinical Trial of its Plasma-Derived Hyperimmune Globulin (IgG) Treatment for Coronavirus Disease (COVID-19)GlobeNewsWire • 03/31/21
Kamada Announces the Closing of the Acquisition of the FDA-Licensed Plasma Collection Center from Blood and Plasma Research, Inc. in the U.S.GlobeNewsWire • 03/03/21
Kamada's (KMDA) CEO Amir London on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/11/21
Kamada Reports Fourth Quarter and Fiscal Year 2020 Financial Results, Recent Achievements and Corporate Development ActivitiesGlobeNewsWire • 02/10/21
Kamada to Announce Fourth Quarter and Fiscal Year Ended December 31, 2020 Financial Results, and Host Conference Call on February 10, 2021GlobeNewsWire • 02/03/21
Kamada Acquires FDA-Licensed Plasma Collection Center from Blood and Plasma Research, Inc. in Texas, USAGlobeNewsWire • 02/01/21
Kamada Selected as a Winner of the Genesis Prize Foundation and Start-Up Nation Central CompetitionGlobeNewsWire • 01/05/21